Exemplary embodiments of the present disclosure are directed towards an in vitro model for human epithelial-mesenchymal transition that occurs during cancer metastases. c-Myc immortalized human primary epithelial cells were engineered to express c-Met, leading to EMT induction. E-Cadherin-GFP served as an assayable ...
Documents
Form DPT-3-02012021_signed
Auditor?s certificate-30122020
Form MSME FORM I-03102020_signed
Form DPT-3-03062020-signed
Form MSME FORM I-31102019_signed
Form MGT-7-31102019_signed
Form AOC-4-31102019_signed
Directors report as per section 134(3)-25102019
List of share holders, debenture holders;-25102019
Optional Attachment-(1)-25102019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-25102019
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-25102019
Form ADT-1-09102019_signed
Copy of written consent given by auditor-04102019
Copy of resolution passed by the company-04102019
Copy of the intimation sent by company-04102019
Optional Attachment-(1)-30062019
Form DPT-3-28062019
Optional Attachment-(1)-28062019
Form MSME FORM I-04062019_signed
Form MSME FORM I-29052019_signed
Optional Attachment-(1)-27032019
Optional Attachment-(2)-27032019
Optional Attachment-(3)-27032019
Form DIR-12-27032019_signed
Form MGT-7-02012019_signed
Form AOC-4-02012019_signed
Directors report as per section 134(3)-30122018
List of share holders, debenture holders;-30122018